Causative organisms and their antibiotic resistance patterns for childhood septic arthritis in China between 1989 and 2008

Orthopedics

Volumn 34, Issue 3, 2011, Pages

  Yu, Fang ^a   Liu, Hua ^a   Li, Kang Hua ^a   Lei, Guang Hua ^a   Gao, Shu Guang ^a   Chen, You ^b   Liu, Tang ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G;

ACINETOBACTER BAUMANNII; ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ARTHRITIS; CHILD; CHINA; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; HUMAN; INFECTIOUS ARTHRITIS; JOINT DISLOCATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; OSTEOMYELITIS; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SCHOOL CHILD; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INTERMEDIUS; STAPHYLOCOCCUS SAPROPHYTICUS; TREATMENT PLANNING; INFANT; MICROBIOLOGY; NEWBORN; PREVALENCE; RISK FACTOR;

ADOLESCENT; ARTHRITIS, INFECTIOUS; CHILD; CHILD, PRESCHOOL; CHINA; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREVALENCE; RISK FACTORS;

EID: 79952527092     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20110124-13     Document Type: Article

References (35)

1. Riise ØR, Handeland KS, Cvancarova M, et al. Incidence and characteristics of arthritis in Norwegian children: a population-based study [published online ahead of print January 28, 2008]. Pediatrics. 2008; 121(2):e299-e306.
2. Nunn TR, Cheung WY, Rollinson PD. A prospective study of pyogenic sepsis of the hip in childhood. J Bone Joint Surg Br. 2007; 89(1):100-106. (Pubitemid 46218421)
3. Geirsson AJ, Statkevicius S, Vikingsson A. Septic arthritis in Iceland 1990-2002: increasing incidence due to iatrogenic infections [published online ahead of print September 27, 2007]. Ann Rheum Dis. 2008; 67(5):638-643.
4. Forlin E, Milani C. Sequelae of septic arthritis of the hip in children: a new classification and a review of 41 hips. J Pediatr Orthop. 2008; 28(5):524-528.
5. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children [published online ahead of print May 6, 2005]. Clin Infect Dis. 2005; 40(12):1785-1791.
6. Belthur MV, Palazzi DL, Miller JA, Phillips WA, Weinberg J. A clinical analysis of shoulder and hip joint infections in children. J Pediatr Orthop. 2009; 29(7):828-833.
7. Kao HC, Huang YC, Chiu CH, et al. Acute hematogenous osteomyelitis and septic arthritis in children. J Microbiol Immunol Infect. 2003; 36(4):260-265.
8. Yagupsky P, Dagan R, Howard CW, Einhorn M, Kassis I, Simu A. High prevalence of Kingella kingae in joint fluid from children with septic arthritis revealed by the BACTEC blood culture system. J Clin Microbiol. 1992; 30(5):1278-1281.
9. Dubost JJ, Soubrier M, De Champs C, Ristori JM, Bussiére JL, Sauvezie B. No changes in the distribution of organisms responsible for septic arthritis over a 20 year period. Ann Rheum Dis. 2002; 61(3):267-269. (Pubitemid 34177762)
10. Ling TK, Xiong J, Yu Y, Lee CC, Ye H, Hawkey PM. Multicenter antimicrobial susceptibility survey of gram-negative bacteria isolated from patients with community-acquired infections in the People's Republic of China. Antimicrob Agents Chemother. 2006; 50(1):374-378. (Pubitemid 43042951)
11. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med. 2002; 136(11):834-844. (Pubitemid 34568654)
12. Newman JH. Review of septic arthritis throughout the antibiotic era. Ann Rheum Dis. 1976; 35(3):198-205.
13. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. 6th ed. Washington, DC: Amer Soc Microbiol Press; 1995.
14. Lyon RM, Evanich JD. Culture-negative septic arthritis in children. J Pediatr Orthop. 1999; 19(5):655-659. (Pubitemid 29416492)
15. Chuang YC, Wang JL, Chen YC, Chang SC. Characteristics and outcomes of community-onset septic arthritis in adults. J Microbiol Immunol Infect. 2009; 42(3):258-264.
16. Matan AJ, Smith JT. Pediatric septic arthritis. Orthopedics. 1997; 20(7):630-635.
17. Ryan MJ, Kavanagh R, Wall PG, Hazleman BL. Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol. 1997; 36(3):370-373.
18. Morgan DS, Fisher D, Merianos A, Currie BJ. An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect. 1996; 117(3):423-428. (Pubitemid 26421687)
19. Kaandorp CJ, Dinant HJ, van de Laar MA, Moens HJ, Prins AP, Dijkmans BA. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis. 1997; 56(8):470-475. (Pubitemid 27396033)
20. Eder L, Zisman D, Rozenbaum M, Rosner I. Clinical features and aetiology of septic arthritis in northern Israel [published online ahead of print September 7, 2005]. Rheumatology (Oxford). 2005; 44(12):1559-1563.
21. Speller DC, Johnson AP, James D, Marples RR, Charlett A, George RC. Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet. 1997; 350(9074):323-325.
22. Klevens RM, Edwards JR, Tenover FC, et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003 [published online ahead of print December 19, 2005]. Clin Infec Dis. 2006; 42(3):389-391.
23. Monnet DL, MacKenzie FM, López-Lozano JM, et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis. 2004; 10(8):1432-1441.
24. Borg MA. Bed occupancy and overcrowding as determinant factors in the incidence of MRSA infections within general ward settings. J Hosp Infect. 2003; 54(4):316-318. (Pubitemid 37554929)
25. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis [published online ahead of print November 6, 2007]. J Antimicrob Chemother. 2008; 61(1):26-38.
26. Zhang W, Shen X, Wang Y, et al. Antibiotic use in five children's hospitals during 2002-2006: the impact of antibiotic guidelines issued by the Chinese Ministry of Health. Pharmacoepidemiol Drug Saf. 2008; 17(3):306-311.
27. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003; 24(5):362-386. (Pubitemid 36612323)
28. Liu Y, Kong F, Zhang X, Brown M, Ma L, Yang Y. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous [published online ahead of print August 20, 2009]. Br J Dermatol. 2009; 161(6):1347-1350.
29. Weston VC, Jones AC, Bradbury N, Fawthrop F, Doherty M. Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991. Ann Rheum Dis. 1999; 58(4):214-219.
30. Zhang R, Eggleston K, Rotimi V, Zeckhauser RJ. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health. 2006; (2):6.
31. O'Neill AJ, Larsen AR, Henriksen AS, Chopra I. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates. Antimicrob Agents Chemother. 2004; 48(9):3594-3597. (Pubitemid 39129370)
32. Granizo JJ, Aguilar L, Casal J, Dal-Ré R, Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother. 2000; 46(6):959-964.
33. Marshall SA, Wilke WW, Pfaller MA, Jones RN. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE Program. Diagn Microbiol Infec Dis. 1998; 30(3):205-214. (Pubitemid 28183802)
34. Garrett DO, Jochimsen E, Murfitt K, et al. The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis. Infect Control Hosp Epidemiol. 1999; 20(3):167-170.
35. Guidelines for antibacterials use in clinical practice. The communique of the Ministry of Health of P.R. China. 2004.